Authors propose that piR_19166, through regulation of the oncogene CTTN, inhibits migration and distant metastasis of prostate cancer cells and may represent a new marker of diagnosis and treatment for PCa patients in early stages [196]. The gene discussed is CTTN; the disease is posterior cortical atrophy.